You are viewing the site in preview mode

Skip to main content

Table 2 Comparison of patient background characteristics between presence or absence of minimal hepatic encephalopathy

From: Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study

  MHE (-) (n = 51) MHE ( +) (n = 48) P value
Age (years) 72 68 0.944
Male, n (%) 34 (66.7) 27 (56.3) 0.287
Etiology    0.677
 HBV, n (%) 11 (21.6) 7 (14.6)  
 HCV (include SVR), n (%) 24 (47.0) 28 (58.3)  
 NBNC, n (%) 16 (31.4) 13 (27.1)  
Taking BCAA, n (%) 11 (21.6) 17 (35.4) 0.126
Taking diuretic, n (%) 12 (23.5) 13 (27.1) 0.684
Alcohol, n (%) 22 (43.1) 17 (35.4) 0.432
Diabetes, n (%) 17 (33.3) 16 (33.3) 1.000
HCC, n (%) 36 (70.6) 34 (75.0) 0.979
Esophageal or gastric varices, n (%) 19 (38.0) 21 (43.8) 0.563
Porto-systemic shunts, n (%) 22 (43.1) 13 (27.1) 0.095
Ascites, n (%) 4 (7.8) 6 (12.5) 0.332
Child–Pugh Class    0.879
 A 30 (66.7) 30 (68.4)  
 B or C 15 (33.3) 14 (31.8)  
Sarcopenia, n (%) 3 (5.9) 3 (6.3) 0.632
Body height (m) 1.61 1.56 0.023
Body weight (kg) 60.8 53.9 0.002
BMI (kg/m2) 24.52 22.66 0.021
Grip strength (kg) 28.3 21.9 0.041
Hemoglobin (g/L) 133 124 0.181
Platelet (× 103/μL) 107 106.5 0.563
ALT (U/L) 26 23 0.385
γ-GTP (U/L) 43 39 0.975
Cholinesterase (U/L) 210 203 0.416
Albumin (g/L) 39 38 0.863
Total cholesterol (mmol/L) 4.16 4.16 0.991
Ammonia (μmol/L) 31.1 30.5 0.674
Prothrombin time (%) 79.0 81.5 0.483
Sodium (mEq/L) 140 139.5 0.946
BCAA (mmol/L) 465.9 404.0 0.093
Tyrosine (mmol/L) 99.5 91.1 0.076
BTR 4.62 4.78 0.978
Subcutaneous fat area (cm2) 119.99 97.35 0.198
Visceral fat area (cm2) 111.37 111.09 0.385
CT level of skeletal muscle (HU) 23.46 22.51 0.287
Skeletal muscle area (cm2) 125.85 108.23 0.003
Skeletal muscle index (cm2/m2) 51.22 46.40 0.027
Psoas muscle area (cm2) 14.34 10.85 0.002
Psoas muscle index (cm2/m2) 5.53 4.24 0.003
  1. Continuous variables are expressed as medians
  2. SMI, skeletal muscle index; PMI, psoas muscle index